Summerset Group delivers Q2 update

Summerset Group saw first-half FY26 sales rise 17%, with resales up 26%.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Summerset Group Holdings Ltd (ASX: SNZ) share price is in focus after the company reported 448 occupation right sales in Q2 FY26, with resales up 26% and total first-half sales up 17% on last year.

Married elderly man and woman in love spending time together on bench on a phone, symbolising retirement.

Image source: Getty Images

What did Summerset Group report?

  • 448 occupation right sales in Q2 FY26 (221 new, 227 resales)
  • Q2 new sales unchanged from a year ago, but resales jumped 26%
  • First-half (1 Jan–30 Jun) total sales up 17% to 813
  • New sales up 12%, resales up 23% year-on-year for the first half
  • Strong sales at four newly opened village centres in NZ and Australia

What else do investors need to know?

Summerset opened four new village centre buildings in the first half of the year, with encouraging early demand. Occupancy rates at these centres ranged from 21% to 45%, highlighting good uptake across both Australian and New Zealand developments.

The group adjusted its New Zealand build rate in the wake of the Iran conflict, reducing its FY26 target to between 600–650 new homes but maintaining group deliveries within its forecast of 700–800, with 454 homes already delivered so far this year. Australian operations remain on track, with Cranbourne North open and Chirnside Park set to open later this year.

What did Summerset Group management say?

Summerset Chief Executive Scott Scoullar said:

Our total first half (1 Jan – 30 Jun) sales were up 17% on the same period last year, with new sales up 12% and resales up 23%… These buildings are central to the resident experience in our villages and provide the care, support and amenity our residents value. We're pleased with the level of interest and sales momentum across these villages' new buildings.

What's next for Summerset Group?

Summerset has reiterated its guidance for a development margin in the 20–25% long-term range, supported by the recent shift towards higher care and apartment sales. The company continues to manage construction in response to broader economic conditions and demand, with flexibility to adjust its build programme.

Investors can look forward to Summerset's half-year FY26 financial results scheduled for Thursday 27 August. Key milestones, including further progress at Australian sites, will also be closely watched.

Summerset Group Holdings share price snapshot

Over the past 12 months, Summerset Group shares have declined 28%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

A small child carrying a brief case tries to reach an elevator button outside closed elevator doors.
Healthcare Shares

Up 1,636%, but can 4DMedical shares reclaim their record high?

Can the US growth story drive the ASX star back to records?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Healthcare Shares

Mesoblast shares: Q4 earnings top projections

Ryoncil® uptake has exceeded initial projections

Read more »

A woman leans forward with her hands shielding her eyes as if she is looking intently for something.
Healthcare Shares

Up 36%: Can CSL shares keep rebounding?

Find out what experts expect from CSL shares next.

Read more »

A man looking at his laptop and thinking.
Healthcare Shares

Is CSL a fallen ASX giant to buy in July?

Confidence has been shaken, but I think the long-term opportunity remains attractive.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

This red-hot ASX healthcare share hit a speed bump. What next?

The tech company must convert innovation into profits to justify its lofty valuation.

Read more »

Two health workers taking a break.
Healthcare Shares

Top broker tips 37% upside for this exciting ASX healthcare stock

This healthcare stock is one to watch.

Read more »

A woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear shares are slipping again. Is the comeback already over?

The healthcare stock needs evidence of recovering demand before rallying further.

Read more »

A young couple sits at their kitchen table looking at documents with a laptop open in front of them.
Healthcare Shares

ResMed's $490m MatrixCare sale: What it means

ResMed announces $490 million sale of MatrixCare and future shareholder returns.

Read more »